Incidence and predictors of ARDS after cardiac surgery

Chest

Volumn 119, Issue 3, 2001, Pages 884-888

  Milot, J ^a   Perron, J ^a   Lacasse, Y ^a   Letourneau L ^a   Cartier, P C ^a   Maltais, F ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

ARDS; Cardiac surgery; Cardiopulmonary bypass

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEART SURGERY; HUMAN; INCIDENCE; MALE; MORTALITY; PRIORITY JOURNAL; SHOCK;

EID: 0035096648     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.3.884     Document Type: Article

References (33)

1. The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
2. Pathology of the adult respiratory distress syndrome
3. The clinical entity of adult respiratory distress syndrome: Definition, prediction, and prognosis
4. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993
5. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction
6. Adult respiratory distress syndrome after cardiac surgery
7. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations
8. Évolution du risque opératoire et de ses facteurs prédictifs en chirurgie coronarienne
9. Reoperative coronary artery bypass grafting
10. An expanded definition of the adult respiratory distress syndrome
11. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome
12. Effect of methylprednisolone on complement activation during heparin neutralization
13. Acute lung injury during cardiopulmonary bypass: Are the neutrophils responsible?
14. Normothermic perfusion and lung function after cardiopulmonary bypass: Effects in pulmonary risk patients
15. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins
16. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability
17. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability
18. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients
19. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass
20. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state
21. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
22. Protamine-induced fatal anaphylaxis: Prevalence of antiprotamine immunoglobulin E antibody
23. Serious adverse reactions to protamine sulfate: Are alternative needed?
24. Adverse reactions to protamine sulfate following cardiac surgery
25. Noncardiogenic pulmonary edema and peripheral collapse following cardiopulmonary bypass: Rare protamine reaction?
26. Protamine-induced fulminating non-cardiogenic pulmonary edema following cardiopulmonary bypass
27. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass
28. Adult respiratory distress syndrome: Risk with common predispositions
29. Clinical predictors of adult respiratory distress syndrome
30. Cardiovascular alterations in the adult respiratory distress syndrome
31. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence, prophylaxis and management
32. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass
33. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators